Artemis Investment Management LLP Sells 157,982 Shares of Avantor, Inc. (NYSE:AVTR)

Artemis Investment Management LLP lowered its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 3.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,882,087 shares of the company’s stock after selling 157,982 shares during the quarter. Avantor makes up 1.2% of Artemis Investment Management LLP’s portfolio, making the stock its 23rd biggest holding. Artemis Investment Management LLP owned approximately 0.57% of Avantor worth $81,796,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. State Street Corp lifted its stake in Avantor by 58.0% in the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock worth $578,666,000 after purchasing an additional 8,206,695 shares in the last quarter. 1832 Asset Management L.P. lifted its position in Avantor by 1,634.9% during the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock valued at $180,839,000 after purchasing an additional 8,038,451 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of Avantor by 653.0% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock worth $159,740,000 after buying an additional 5,354,678 shares in the last quarter. FMR LLC increased its holdings in shares of Avantor by 557.2% in the 3rd quarter. FMR LLC now owns 4,675,283 shares of the company’s stock worth $120,950,000 after buying an additional 3,963,912 shares during the last quarter. Finally, Sound Shore Management Inc. CT purchased a new stake in shares of Avantor during the 2nd quarter valued at about $76,412,000. Institutional investors own 95.08% of the company’s stock.

Avantor Price Performance

Avantor stock opened at $22.14 on Friday. The stock has a market cap of $15.07 billion, a price-to-earnings ratio of 48.13, a price-to-earnings-growth ratio of 3.42 and a beta of 1.28. The firm has a 50-day moving average of $21.45 and a two-hundred day moving average of $23.35. Avantor, Inc. has a 1 year low of $19.59 and a 1 year high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06.

Analyst Ratings Changes

AVTR has been the subject of several recent research reports. Wells Fargo & Company dropped their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Robert W. Baird dropped their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. UBS Group restated a “neutral” rating and set a $25.00 price target (down previously from $29.00) on shares of Avantor in a report on Friday. Royal Bank of Canada reaffirmed an “outperform” rating and set a $34.00 price objective on shares of Avantor in a research note on Thursday, September 26th. Finally, Barclays reduced their target price on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $27.38.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.